Eiraku, M. et al. Self-organized formation of polarized cortical tissues from ESCs and its active manipulation by extrinsic signals. Cell Stem Cell 3, 519–532 (2008).
Marsee, A. et al. Building consensus on definition and nomenclature of hepatic, pancreatic, and biliary organoids. Cell Stem Cell 28, 816–832 (2021).
Sato, T. et al. Single Lgr5 stem cells build crypt–villus structures in vitro without a mesenchymal niche. Nature 459, 262–265 (2009).
Spence, J. R. et al. Directed differentiation of human pluripotent stem cells into intestinal tissue in vitro. Nature 470, 105–109 (2011).
Jiang, S. et al. Macrophage–organoid co-culture model for identifying treatment strategies against macrophage-related gemcitabine resistance. J. Exp. Clin. Cancer Res. 42, 199 (2023).
CAS PubMed PubMed Central Google Scholar
Zhou, G. et al. Modelling immune cytotoxicity for cholangiocarcinoma with tumour-derived organoids and effector T cells. Br. J. Cancer 127, 649–660 (2022).
CAS PubMed PubMed Central Google Scholar
Liu, J. et al. Cancer-associated fibroblasts provide a stromal niche for liver cancer organoids that confers trophic effects and therapy resistance. Cell. Mol. Gastroenterol. Hepatol. 11, 407–431 (2021).
Willemse, J., van der Laan, L. J. W., de Jonge, J. & Verstegen, M. M. A. Design by nature: emerging applications of native liver extracellular matrix for cholangiocyte organoid-based regenerative medicine. Bioengineering 9, 110 (2022).
PubMed PubMed Central Google Scholar
van Tienderen, G. S. et al. Extracellular matrix drives tumor organoids toward desmoplastic matrix deposition and mesenchymal transition. Acta Biomater. 158, 115–131 (2023).
Ingber, D. E. Human organs-on-chips for disease modelling, drug development and personalized medicine. Nat. Rev. Genet. 23, 467–491 (2022).
CAS PubMed PubMed Central Google Scholar
Matai, I., Kaur, G., Seyedsalehi, A., McClinton, A. & Laurencin, C. T. Progress in 3D bioprinting technology for tissue/organ regenerative engineering. Biomaterials 226, 119536 (2020).
Hendriks, D. et al. Engineered human hepatocyte organoids enable CRISPR-based target discovery and drug screening for steatosis. Nat. Biotechnol. 41, 1567–1581 (2023).
CAS PubMed PubMed Central Google Scholar
Hendriks, D., Artegiani, B., Hu, H., Chuva de Sousa Lopes, S. & Clevers, H. Establishment of human fetal hepatocyte organoids and CRISPR–Cas9-based gene knockin and knockout in organoid cultures from human liver. Nat. Protoc. 16, 182–217 (2021).
Sampaziotis, F. et al. Cholangiocyte organoids can repair bile ducts after transplantation in the human liver. Science 371, 839–846 (2021).
CAS PubMed PubMed Central Google Scholar
Ahn, S. J. Standards for organoids. Int. J. Stem Cells 17, 99–101 (2024).
Ahn, S. J. et al. Essential guidelines for manufacturing and application of organoids. Int. J. Stem Cells 17, 102–112 (2024).
Kelley, K. W. & Pașca, S. P. Human brain organogenesis: toward a cellular understanding of development and disease. Cell 185, 42–61 (2022).
Bombieri, C. et al. Advanced cellular models for rare disease study: exploring neural, muscle and skeletal organoids. Int. J. Mol. Sci. 25, 1014 (2024).
CAS PubMed PubMed Central Google Scholar
Okumuş, E. B., Böke, Ö. B., Turhan, S. & Doğan, A. From development to future prospects: the adipose tissue & adipose tissue organoids. Life Sci. 351, 122758 (2024).
Wang, X. H., Liu, N., Zhang, H., Yin, Z. S. & Zha, Z. G. From cells to organs: progress and potential in cartilaginous organoids research. J. Transl. Med. 21, 926 (2023).
CAS PubMed PubMed Central Google Scholar
Neal, J. T. et al. Organoid modeling of the tumor immune microenvironment. Cell 175, 1972–1988 (2018).
CAS PubMed PubMed Central Google Scholar
Schuth, S. et al. Patient-specific modeling of stroma-mediated chemoresistance of pancreatic cancer using a three-dimensional organoid–fibroblast co-culture system. J. Exp. Clin. Cancer Res. 41, 312 (2022).
CAS PubMed PubMed Central Google Scholar
Strating, E. et al. Co-cultures of colon cancer cells and cancer-associated fibroblasts recapitulate the aggressive features of mesenchymal-like colon cancer. Front. Immunol. 14, 1053920 (2023).
CAS PubMed PubMed Central Google Scholar
Homan, K. A. et al. Flow-enhanced vascularization and maturation of kidney organoids in vitro. Nat. Methods 16, 255–262 (2019).
CAS PubMed PubMed Central Google Scholar
Willemse, J. et al. Scaffolds obtained from decellularized human extrahepatic bile ducts support organoids to establish functional biliary tissue in a dish. Biotechnol. Bioeng. 118, 836–851 (2021).
Rüland, L. et al. Organoid models of fibrolamellar carcinoma mutations reveal hepatocyte transdifferentiation through cooperative BAP1 and PRKAR2A loss. Nat. Commun. 14, 2377 (2023).
PubMed PubMed Central Google Scholar
Lawlor, K. T. et al. Cellular extrusion bioprinting improves kidney organoid reproducibility and conformation. Nat. Mater. 20, 260–271 (2021).
Bernal, P. N. et al. Volumetric bioprinting of organoids and optically tuned hydrogels to build liver-like metabolic biofactories. Adv. Mater. 34, e2110054 (2022).
Wang, X., Luo, Y., Ma, Y., Wang, P. & Yao, R. Converging bioprinting and organoids to better recapitulate the tumor microenvironment. Trends Biotechnol. 42, 648–663 (2024).
Chen, H. et al. Acoustic bioprinting of patient-derived organoids for predicting cancer therapy responses. Adv. Healthc. Mater. 11, e2102784 (2022).
Brassard, J. A., Nikolaev, M., Hübscher, T., Hofer, M. & Lutolf, M. P. Recapitulating macro-scale tissue self-organization through organoid bioprinting. Nat. Mater. 20, 22–29 (2021).
Urciuolo, A. et al. Hydrogel-in-hydrogel live bioprinting for guidance and control of organoids and organotypic cultures. Nat. Commun. 14, 3128 (2023).
CAS PubMed PubMed Central Google Scholar
Yarali, E. et al. 4D printing for biomedical applications. Adv. Mater. 36, e2402301 (2024).
Chen, A. et al. Multimaterial 3D and 4D bioprinting of heterogenous constructs for tissue engineering. Adv. Mater. 36, e2307686 (2023).
Chadwick, M. et al. Rapid processing and drug evaluation in glioblastoma patient-derived organoid models with 4D bioprinted arrays. iScience 23, 101365 (2020).
CAS PubMed PubMed Central Google Scholar
Schuster, B. et al. Automated microfluidic platform for dynamic and combinatorial drug screening of tumor organoids. Nat. Commun. 11, 5271 (2020).
CAS PubMed PubMed Central Google Scholar
Shi, H. et al. Organoid intelligence: integration of organoid technology and artificial intelligence in the new era of in vitro models. Med. Nov. Technol. Devices 21, 100276 (2024).
Bai, L. et al. AI-enabled organoids: construction, analysis, and application. Bioact. Mater. 31, 525–548 (2024).
Du, X. et al. Organoids revealed: morphological analysis of the profound next generation in-vitro model with artificial intelligence. Biodes. Manuf. 6, 319–339 (2023).
Fujii, M. & Sato, T. Somatic cell-derived organoids as prototypes of human epithelial tissues and diseases. Nat. Mater. 20, 156–169 (2021).
Viergever, B. J. et al. Urine-derived bladder cancer organoids (urinoids) as a tool for cancer longitudinal response monitoring and therapy adaptation. Br. J. Cancer 130, 369–379 (2024).
Sun, G. et al. Formation and optimization of three-dimensional organoids generated from urine-derived stem cells for renal function in vitro. Stem Cell Res. Ther. 11, 309 (2020).
Soroka, C. J. et al. Bile-derived organoids from patients with pri
Comments (0)